AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quinlivan, E. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quinlivan, E. P
Agricola
Right arrow Articles by Quinlivan, E. P
American Journal of Clinical Nutrition, Vol. 87, No. 5, 1537-1538, May 2008
© 2008 American Society for Nutrition


LETTER TO THE EDITOR

Calculation of steady state conditions and elimination kinetics of red blood cell folate in women of childbearing age after daily supplementation with various forms and doses of folate

Eoin P Quinlivan

Biomedical Mass Spectrometry Laboratory
General Clinical Research Center
University of Florida
PO Box 100322
Gainesville, FL 32611-0322
E-mail: epq{at}ufl.edu

Dear Sir:

In a recent issue of the Journal, Pietrzik et al (1) described a model for calculating the appearance and elimination kinetics of red blood cell (RBC) folate. However, the authors made several erroneous assumptions in deriving this model.

The pharmokinetic principle on which their model is based is valid only for reactions that follow first-order kinetics (eg, radioactive decay) in which the analyte concentration halves every half-life—eg, 1/2 remains after 1 half-life, 1/4 remains after 2 half-lives, and so on. However, RBC turnover does not follow first-order kinetics. Instead, each cell has a finite life span, and the cells are removed from circulation after 13–21 wk (mean: {approx}17 wk) (2). This phenomenon was aptly illustrated by Lin et al (3) who, after administering a single dose of [14C]folic acid, showed that the loss of RBC [14C]folate occurred primarily between the 13th and 21st wk after administration of the label and that a mean RBC residency of labeled folate was 16 wk. Thus, after 12 wk (the equivalent of 1.5 so-called "half-lives"), nearly all of the RBCs produced on day 1 would be intact—compared with only {approx}35% (0.51.5) that would be predicted if the reaction followed first-order kinetics. Moreover, after 20 wk (2.5 half-lives), none of the day 1 RBCs should remain—compared with {approx}18% (0.52.5) that would be predicted by first-order kinetics. The fact that RBC folate does not obey first-order kinetics was also reported in the 1960s by Herbert (4), who showed that RBC concentrations decreased linearly in a subject consuming a severely folate-deficient diet ({approx}5 µg folate acid/d) and reached a minimum ({approx}10 ng/mL) after {approx}18 wk depletion.

Circulating blood (2) contains a mixture of RBCs of different ages (0 to {approx}17 wk). Thus, when discussing RBCs, the term "half-life" refers to the fact that, after one half-life ({approx}8.5 wk), roughly one-half of the original RBC population (the older RBCs) will no longer be in circulation (replaced by new RBCs). Thus, the turnover of an RBC population is linear (ie, all of the RBCs are replaced every 2 half-lives), whereas the change in population resulting from a first-order reaction would be exponential.

Moreover, Pietrzik et al (1) assumed that the RBC folate concentration had not reached a maximum after 24 wk of fortification. However, because no samples were collected after 24 wk, it is not possible to determine whether the RBC folate concentration increased after this period or whether it reached a plateau between 16 and 24 wk. Because the maximum life span of RBCs is 21 wk (2), it should take at least that long for RBC folate concentrations to plateau. However, plateau RBC folate enrichment may be further delayed by the amount of time it takes for the RBC progenitor cells, presumably in the bone marrow, to reach maximum enrichment. The rate at which RBC folate concentrations increase is also a function of the rate at which the progenitor cells become folate enriched.

In conclusion, because RBC production and loss do not follow first-order kinetics, a pharmokinetic model based on first-order kinetics cannot be used to predict the appearance of folate in the RBCs and its elimination from the RBCs. Therefore, there is no scientific basis for the model reported by Pietrzik et al (1).

ACKNOWLEDGMENTS

The author had no personal or financial conflict of interest.

REFERENCES

  1. Pietrzik K, Lamers Y, Bramswig S, Prinz-Langenohl R. Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women of childbearing age. Am J Clin Nutr 2007;86:1414–9.[Abstract/Free Full Text]
  2. Landaw SA. Homeostasis, survival, and red cell kinetics: measurement and imaging of red cell production. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, eds. Hematology: basic principles and practice. New York, NY: Churchill Livingstone, 1991:274–90.
  3. Lin Y, Dueker SR, Follett JR, et al. Quantitation of in vivo human folate metabolism. Am J Clin Nutr 2004;80:680–91.[Abstract/Free Full Text]
  4. Herbert V. Experimental nutritional folate deficiency in man. Trans Assoc Am Physicians 1962;75:307–20.[Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quinlivan, E. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quinlivan, E. P
Agricola
Right arrow Articles by Quinlivan, E. P


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS